Themis Medicare Limited (THEMISMED.BO)
INR 273.3
(0.64%)
INR 273.3
(0.64%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 957.92 Million INR | 3.7% |
| 2022 | 923.75 Million INR | 15.86% |
| 2021 | 797.32 Million INR | -8.54% |
| 2020 | 871.82 Million INR | -12.77% |
| 2019 | 999.43 Million INR | 22.18% |
| 2018 | 818.02 Million INR | 2.25% |
| 2017 | 799.99 Million INR | 21.48% |
| 2016 | 658.56 Million INR | -28.4% |
| 2015 | 919.83 Million INR | -28.37% |
| 2014 | 1.28 Billion INR | -0.84% |
| 2013 | 1.29 Billion INR | -9.02% |
| 2012 | 1.42 Billion INR | 1.48% |
| 2011 | 1.4 Billion INR | 130.36% |
| 2010 | 608.88 Million INR | -50.68% |
| 2009 | 1.23 Billion INR | -1.4% |
| 2008 | 1.25 Billion INR | 10.91% |
| 2007 | 1.12 Billion INR | 34.21% |
| 2006 | 841.14 Million INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 814.53 Million INR | 0.0% |
| 2023 Q2 | 945.87 Million INR | 0.0% |
| 2023 Q4 | 957.92 Million INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 FY | 957.92 Million INR | 3.7% |
| 2023 Q3 | - INR | -100.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 923.75 Million INR | 0.0% |
| 2022 Q2 | 764.54 Million INR | 0.0% |
| 2022 FY | 923.75 Million INR | 15.86% |
| 2022 Q1 | - INR | -100.0% |
| 2021 FY | 797.32 Million INR | -8.54% |
| 2021 Q4 | 797.32 Million INR | 0.0% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 Q2 | 667.53 Million INR | 0.0% |
| 2020 Q4 | 871.82 Million INR | 0.0% |
| 2020 FY | 871.82 Million INR | -12.77% |
| 2020 Q2 | 836.25 Million INR | 0.0% |
| 2019 Q4 | 999.43 Million INR | 0.0% |
| 2019 FY | 999.43 Million INR | 22.18% |
| 2019 Q2 | 771.74 Million INR | 0.0% |
| 2018 Q4 | 818.02 Million INR | 0.0% |
| 2018 FY | 818.02 Million INR | 2.25% |
| 2017 FY | 799.99 Million INR | 21.48% |
| 2017 Q4 | 799.99 Million INR | 0.0% |
| 2017 Q2 | 701.24 Million INR | 0.0% |
| 2016 FY | 658.56 Million INR | -28.4% |
| 2016 Q4 | 956.57 Million INR | 0.0% |
| 2016 Q2 | 1.03 Billion INR | 0.0% |
| 2015 FY | 919.83 Million INR | -28.37% |
| 2015 Q2 | 1.24 Billion INR | 0.0% |
| 2015 Q4 | 919.83 Million INR | 0.0% |
| 2014 Q4 | 1.28 Billion INR | 0.0% |
| 2014 FY | 1.28 Billion INR | -0.84% |
| 2013 FY | 1.29 Billion INR | -9.02% |
| 2012 FY | 1.42 Billion INR | 1.48% |
| 2012 Q4 | 1.42 Billion INR | 0.0% |
| 2012 Q2 | 1.27 Billion INR | 0.0% |
| 2011 FY | 1.4 Billion INR | 130.36% |
| 2010 FY | 608.88 Million INR | -50.68% |
| 2009 FY | 1.23 Billion INR | -1.4% |
| 2008 FY | 1.25 Billion INR | 10.91% |
| 2007 FY | 1.12 Billion INR | 34.21% |
| 2006 FY | 841.14 Million INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Ajanta Pharma Limited | 352.8 Million INR | -171.52% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -5442.568% |
| Sigachi Industries Limited | 1.43 Billion INR | 33.037% |
| Bal Pharma Limited | 1.39 Billion INR | 31.405% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -476.312% |
| Medico Remedies Limited | 80.5 Million INR | -1089.906% |
| Lasa Supergenerics Limited | 220.76 Million INR | -333.916% |
| Venus Remedies Limited | 413.3 Million INR | -131.774% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -56.651% |
| Alpa Laboratories Limited | 52.46 Million INR | -1725.831% |
| Nectar Lifesciences Limited | 6.35 Billion INR | 84.927% |
| Shilpa Medicare Limited | 9.37 Billion INR | 89.781% |
| Aarti Drugs Limited | 5.64 Billion INR | 83.024% |
| Lupin Limited | 29.21 Billion INR | 96.721% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 98.559% |
| Zydus Lifesciences Limited | 8.04 Billion INR | 88.089% |
| Windlas Biotech Limited | 36.41 Million INR | -2530.931% |
| Suven Life Sciences Limited | 7.09 Million INR | -13397.562% |
| Eris Lifesciences Limited | 27.81 Billion INR | 96.556% |
| Valiant Laboratories Limited | 767.08 Million INR | -24.878% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | 74.635% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | 90.53% |
| Ipca Laboratories Limited | 14.38 Billion INR | 93.34% |
| Bliss GVS Pharma Limited | 998.4 Million INR | 4.054% |
| Achyut Healthcare Limited | - INR | -Infinity% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 97.074% |
| Bajaj HealthCare Limited | 3.32 Billion INR | 71.218% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Mankind Pharma Limited | 2.07 Billion INR | 53.762% |
| Laurus Labs Limited | 25.77 Billion INR | 96.283% |
| Piramal Pharma Limited | 47.1 Billion INR | 97.966% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -32.152% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 97.618% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | 81.333% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | 92.218% |
| Unichem Laboratories Limited | 2.47 Billion INR | 61.298% |
| Sequent Scientific Limited | 4.87 Billion INR | 80.358% |
| Novartis India Limited | 69.7 Million INR | -1274.35% |
| Wanbury Limited | 1.16 Billion INR | 17.764% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -47.381% |
| Wockhardt Limited | 23.56 Billion INR | 95.934% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -971.381% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 97.386% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -458.62% |
| Dr. Reddy's Laboratories Limited | 20.02 Billion INR | 95.215% |
| Divi's Laboratories Limited | 30 Million INR | -3093.073% |
| NATCO Pharma Limited | 3.71 Billion INR | 74.194% |
| Gufic Biosciences Limited | 3.32 Billion INR | 71.226% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -192.406% |
| Ind-Swift Limited | 10.13 Billion INR | 90.553% |
| Procter & Gamble Health Limited | 95.6 Million INR | -902.01% |
| FDC Limited | 205.18 Million INR | -366.858% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | 50.477% |
| Granules India Limited | 13.15 Billion INR | 92.716% |
| Medicamen Biotech Limited | 308.17 Million INR | -210.84% |
| Alkem Laboratories Limited | 14.18 Billion INR | 93.247% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -1983.254% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -21725.518% |
| Brooks Laboratories Limited | 56.41 Million INR | -1597.871% |
| Megasoft Limited | 1.47 Billion INR | 34.856% |
| ZIM Laboratories Limited | 1.08 Billion INR | 11.975% |
| Strides Pharma Science Limited | 25.16 Billion INR | 96.194% |
| Neuland Laboratories Limited | 953.89 Million INR | -0.422% |
| Morepen Laboratories Limited | 289.99 Million INR | -230.327% |
| Hikal Limited | 8.17 Billion INR | 88.283% |
| Indoco Remedies Limited | 6.71 Billion INR | 85.744% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | 66.418% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -202.694% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | 2.742% |
| Hester Biosciences Limited | 2.44 Billion INR | 60.802% |